N. O’Gorman

5.4k total citations · 5 hit papers
43 papers, 3.4k citations indexed

About

N. O’Gorman is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, N. O’Gorman has authored 43 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Obstetrics and Gynecology, 24 papers in Pediatrics, Perinatology and Child Health and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in N. O’Gorman's work include Pregnancy and preeclampsia studies (29 papers), Prenatal Screening and Diagnostics (11 papers) and Birth, Development, and Health (10 papers). N. O’Gorman is often cited by papers focused on Pregnancy and preeclampsia studies (29 papers), Prenatal Screening and Diagnostics (11 papers) and Birth, Development, and Health (10 papers). N. O’Gorman collaborates with scholars based in United Kingdom, Ireland and Hong Kong. N. O’Gorman's co-authors include K. H. Nicolaides, Liona C. Poon, D. Wright, Argyro Syngelaki, Ranjit Akolekar, Daniel L. Rolnik, W. Plasencia, George Papaioannou, C. de Paco Matallana and Jacques Jani and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Obstetrics and Gynecology.

In The Last Decade

N. O’Gorman

38 papers receiving 3.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

2017 1.4k citations Daniel L. Rolnik, D. Wright et al. profile →
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

2015 442 citations N. O’Gorman, D. Wright et al. American Journal of Obstetrics and Gynecology profile →
ASPRE trial: performance of screening for preterm pre‐eclampsia

2017 276 citations Daniel L. Rolnik, D. Wright et al. Ultrasound in Obstetrics and Gynecology profile →
Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

2018 247 citations Min Yi Tan, Argyro Syngelaki et al. Ultrasound in Obstetrics and Gynecology profile →
Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations

2017 228 citations N. O’Gorman, D. Wright et al. Ultrasound in Obstetrics and Gynecology profile →

Peers

Countries citing papers authored by N. O’Gorman

Since Specialization

Citations

This map shows the geographic impact of N. O’Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. O’Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. O’Gorman more than expected).

Fields of papers citing papers by N. O’Gorman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. O’Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. O’Gorman. The network helps show where N. O’Gorman may publish in the future.

Co-authorship network of co-authors of N. O’Gorman

This figure shows the co-authorship network connecting the top 25 collaborators of N. O’Gorman. A scholar is included among the top collaborators of N. O’Gorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. O’Gorman. N. O’Gorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aspirin, Birthweight, and Large‐For‐Gestational‐Age Neonates: A Secondary Analysis of the ASPRE Trial 2025 ·BJOG An International Journal of Obstetrics & Gynaecology ·Daniel L. Rolnik, Liona C. Poon, Argyro Syngelaki, David Wright, N. O’Gorman, C. de Paco Matallana, Ranjit Akolekar, D. Janga, Mandeep Singh, Francisca S. Molina, Nicola Persico, Jacques Jani, W. Plasencia, (unknown), (unknown), Hamutal Meiri, Kypros H. Nicolaides	0
2	The IRELAnD study—investigating the role of early low-dose aspirin in diabetes mellitus: a double-blinded, placebo-controlled, randomized trial 2024 ·American Journal of Obstetrics & Gynecology MFM ·Catherine Finnegan, Patrick Dicker, Denisa Asandei, Mary Higgins, N. O’Gorman, (unknown), Fidelma Dunne, G Gaffney, Christine Newman, Fionnuala M. McAuliffe, (unknown), (unknown), Fergal D. Malone, Fionnuala Breathnach	4
3	Perinatal and neonatal outcomes of high-risk asymptomatic women from a specialist preterm birth surveillance clinic 2024 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), Daniel L. Rolnik, Bonnie L. Burke, S. Daly, N. O’Gorman	0
4	ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy 2023 ·Ultrasound in Obstetrics and Gynecology ·Daniel L. Rolnik, Argyro Syngelaki, N. O’Gorman, David C. Wright, Liona C. Poon, K. H. Nicolaides	16
5	Psychological Impact and Women’s Evaluation of the First-Trimester Pre-Eclampsia Screening and Prevention: ASPRE Trial 2023 ·International Journal of Environmental Research and Public Health ·Ana V. Nikčević, Chiara Sacchi, Claudia Marino, N. O’Gorman, Liona C. Poon, K. H. Nicolaides	2
6	Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy 2023 ·American Journal of Obstetrics and Gynecology ·Daniel L. Rolnik, Argyro Syngelaki, N. O’Gorman, D. Wright, K. H. Nicolaides, Liona C. Poon	6
7	A cross-sectional survey of women’s views and preferences for preterm birth screening and treatment 2023 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), Bonnie L. Burke, Lucia F. O’Sullivan, Stephen W. Lindow, N. O’Gorman	2
8	Perspectives on the Use of Placental Growth Factor (PlGF) in the Prediction and Diagnosis of Pre-Eclampsia: Recent Insights and Future Steps 2023 ·International Journal of Women s Health ·(unknown), N. O’Gorman, Kirsten R. Palmer, Fabrício da Silva Costa, Daniel L. Rolnik	20
9	Preterm Birth: Screening and Prediction 2023 ·International Journal of Women s Health ·(unknown), Daniel L. Rolnik, Stephen W. Lindow, N. O’Gorman	4
10	Heterogeneity in defining fetal corpus callosal pathology: systematic review 2020 ·Ultrasound in Obstetrics and Gynecology ·Houman Mahallati, Alexandros Sotiriadis, (unknown), A. Millischer, P. Sonigo, D. Grévent, N. O’Gorman, Nadia Bahi‐Buisson, Tania Attié‐Bitach, Y. Ville, L. J. Salomon	19
11	Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial 2019 ·Obstetrical & Gynecological Survey ·Valérie Malan, L. Bussières, Norbert Winer, (unknown), Amandine Baptiste, Marc Le Lorc’h, Caroline Elie, N. O’Gorman, N. Fries, V. Houfflin‐Debarge, Loı̈c Sentilhes, Michel Vekemans, Y. Ville, Laurent Salomon	3
12	Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia 2018 ·Obstetrical & Gynecological Survey ·Daniel L. Rolnik, D. Wright, Liona C. Poon, N. O’Gorman, Argyro Syngelaki, C. de Paco Matallana, Ranjit Akolekar, S. Cicero, D. Janga, Mandeep Singh, Francisca S. Molina, Nicola Persico, Jacques Jani, W. Plasencia, George Papaioannou, Kinneret Tenenbaum-Gavish, Hamutal Meiri, Sveinbjörn Gizurarson, Kate Maclagan, K. H. Nicolaides	25
13	Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation breakdown → 2018 ·Ultrasound in Obstetrics and Gynecology ·Min Yi Tan, Argyro Syngelaki, Liona C. Poon, Daniel L. Rolnik, N. O’Gorman, Juan Luis Delgado⋈, Ranjit Akolekar, (unknown), (unknown), S. Galeva, (unknown), Francisca S. Molina, Nicola Persico, Jacques Jani, W. Plasencia, Elena Greco, George Papaioannou, A Wright, D. Wright, K. H. Nicolaides	247
14	Predictive performance of the competing risk model in screening for preeclampsia 2018 ·American Journal of Obstetrics and Gynecology ·D. Wright, Min Yi Tan, N. O’Gorman, Liona C. Poon, Argyro Syngelaki, Alan Wright, K. H. Nicolaides	144
15	Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations breakdown → 2017 ·Ultrasound in Obstetrics and Gynecology ·N. O’Gorman, D. Wright, Liona C. Poon, Daniel L. Rolnik, Argyro Syngelaki, M. De Alvarado, Ilma Floriana Carbone, V. Dütemeyer, M. Fiolna, Alexander Frick, (unknown), (unknown), C. de Paco Matallana, George Papaioannou, (unknown), W. Plasencia, K. H. Nicolaides	228
16	ASPRE trial: performance of screening for preterm pre‐eclampsia breakdown → 2017 ·Ultrasound in Obstetrics and Gynecology ·Daniel L. Rolnik, D. Wright, Liona C. Poon, Argyro Syngelaki, N. O’Gorman, C. de Paco Matallana, Ranjit Akolekar, S. Cicero, D. Janga, Mandeep Singh, Francisca S. Molina, Nicola Persico, Jacques Jani, W. Plasencia, George Papaioannou, K. Tenenbaum‐Gavish, K. H. Nicolaides	276
17	Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE) 2016 ·BMJ Open ·N. O’Gorman, D. Wright, Daniel L. Rolnik, K. H. Nicolaides, Liona C. Poon	62
18	Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year 2016 ·Journal of Obstetrics and Gynaecology ·(unknown), (unknown), N. O’Gorman, Stephen Morris, Anna L. David	8
19	Clinico-pathological study of cervical polyps 2010 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), N. O’Gorman, Dan Selo‐Ojeme	16
20	The Role of Toll-Like Receptors (TLR-2 and -4) and Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) in Human Term and Preterm Labor 2009 ·Reproductive Sciences ·(unknown), Marie Anne Ledingham, (unknown), N. O’Gorman, Fiona Jordan, Anne Young, Jane E. Norman	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact